Lysosomal Storage Disorder Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Lysosomal Storage Disorder stocks.

Lysosomal Storage Disorder Stocks Recent News

Date Stock Title
May 10 FOLD Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript
May 10 SGMO Sangamo Therapeutics Reports Q1 2024 Results: A Deep Dive into Financials and Strategic Highlights
May 10 FOLD Amicus Therapeutics Inc (FOLD) Q1 2024 Earnings: Surpasses Revenue Estimates and Projects ...
May 10 FOLD Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
May 10 FOLD Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
May 9 SGMO Sangamo Therapeutics, Inc. (SGMO) Q1 2024 Earnings Call Transcript
May 9 FATE Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
May 9 SGMO Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
May 9 SGMO Sangamo Therapeutics GAAP EPS of -$0.27 misses by $0.05, revenue of $0.48M misses by $5.88M
May 9 FATE Fate Therapeutics GAAP EPS of -$0.47 in-line, revenue of $1.93M beats by $0.67M
May 9 FATE Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
May 9 SGMO Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
May 9 FOLD Amicus Therapeutics, Inc. (FOLD) Q1 2024 Earnings Call Transcript
May 9 BMRN (BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
May 9 FATE Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program
May 9 FOLD Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue Estimates
May 9 SGMO Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing
May 9 FOLD Amicus Therapeutics reports mixed Q1 results; updates FY24 outlook
May 9 FOLD Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
May 8 FATE Fate Therapeutics Q1 2024 Earnings Preview
Lysosomal Storage Disorder

Lysosomal Storage Disorders (LSDs) are a group of inherited metabolic disorders caused by the deficiency of lysosomal enzymes. These enzymes are responsible for breaking down and recycling certain molecules in the body. When these enzymes are deficient, the molecules accumulate in the lysosomes, leading to cell damage and organ dysfunction. Symptoms of LSDs vary depending on the specific disorder, but can include organ enlargement, skeletal abnormalities, developmental delays, and neurological problems.

Browse All Tags